AFP ratio predicts HCC recurrence after liver transplantation-Reference-Cited by-同舟云学术

AFP ratio predicts HCC recurrence after liver transplantation

Published:2020-07-02 Issue:7 Volume:15 Page:e0235576
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Koch Christine^ORCID,Bette Theresa,Waidmann Oliver,Filmann Natalie,Schrecker Christopher,Trojan Jörg,Weiler Nina,Vermehren Johannes,Schnitzbauer Andreas A.,Bechstein Wolf Otto,Zeuzem Stefan,Herrmann Eva,Welker Martin-Walter

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference33 articles.

1. Liver transplantation in the MELD era—analysis of the OPTN/UNOS registry;M Taniguchi;Clin Transpl,2012

2. Liver Transplantation: East versus West;A Shukla;J Clin Exp Hepatol,2013

3. Twenty-year longitudinal follow-up after orthotopic liver transplantation: a single-center experience of 313 consecutive cases;WN Schoening;Am J Transpl,2013

4. The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time;HY Yoo;J Clin Oncol,2003

5. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis;V Mazzaferro;N Engl J Med,1996

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor Mutational Burden from Circulating Tumor DNA Predicts Recurrence of Hepatocellular Carcinoma After Resection: An Emerging Biomarker for Surveillance;Annals of Surgery;2024-06-11

2. Development of a nomogram for predicting liver transplantation prognosis in hepatocellular carcinoma;World Journal of Gastroenterology;2024-06-07

3. Integrated analysis of tumour-derived exosome-related immune genes to predict progression and immune status of hepatocellular carcinoma;Clinical Immunology;2023-11

4. β-Sitosterol activates autophagy to inhibit the development of hepatocellular carcinoma by regulating the complement C5a receptor 1/alpha fetoprotein axis;European Journal of Pharmacology;2023-10

5. Upregulation of helicase-like transcription factor predicts poor prognosis and facilitates hepatocellular carcinoma progression;Human Cell;2023-05-25